Skip to main content
Apellis Pharmaceuticals, Inc. (FRA:1JK)
Germany flag Germany · Delayed Price · Currency is EUR
18.34
+0.75 (4.28%)
At close: Dec 5, 2025

Revenue

Fiscal year is January - December.
Fiscal Year
 TTM FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
 Sep '25 Dec '24 Dec '23 Dec '22 Dec '21
EMPAVELI Revenue
90.67M98.09M
Log In
Log In
Log In
SYFOVRE Revenue
599.54M611.86M
Log In
Log In
Log In
Total Product Revenue
690.21M709.95M
Log In
Log In
Log In
Licensing and Other Revenue
326.18M71.41M
Log In
Log In
Log In
Revenue (Other)
-1.00K-
Log In
Log In
Log In
Revenue (Total)
1.02B781.37M
Log In
Log In
Log In